Navigation Links
Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
Date:3/22/2010

PHILADELPHIA, March 22 /PRNewswire/ -- The Superior Court of Pennsylvania has reinstated an appeal filed by John R. DePhillipo, former Chief Executive Officer of GeneLink Biosciences, and his wife Maria. The appeal had been dismissed by an order from the same court on February 18, 2010. The Superior Court also ordered "The Prothonotary to list the matter for argument before the first available panel."

Originally, DePhillipo and his wife filed suit against GeneLink and GeneWize, a wholly owned Subsidiary of GeneLink, claiming they were induced to settle an Atlantic County, N.J. law suit by fraud. The complaint alleged that GeneLink's attorney made false representations to John DePhillipo, his lawyer and the trial judge relative to the alleged poor economic well being of GeneLink. ("Defendant GeneLink, Inc. was in such dire financial straits that he didn't know how they were able to pay his attorneys fees.")

Within an hour after the DePhillipos settled the Atlantic County case, GeneLink officers filed a press release revealing, for the first time, the existence of their wholly owned subsidiary, GeneWize. They also added that GeneWize had sold approximately 250 presidential founder memberships for One Thousand ($1000.00) dollars and over 4,000 GeneWize dealerships for Five Hundred ($500.00)

The Common Pleas Court Philadelphia judge dismissed the case ruling that GeneLink's lawyer was only puffing. The appeal to the Superior Court followed.

SOURCE GUSTINE J. PELAGATTI & ASSOCIATES

Back to top
'/>"/>
SOURCE GUSTINE J. PELAGATTI & ASSOCIATES
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Appeal of Lawsuit by Former Officer Dismissed; Request for Sanctions Granted
2. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
3. deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal
4. Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group
5. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
6. Court of Appeals Overturns 2005 Patent Verdict Against Cordis
7. Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R)
8. WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10, 2008
9. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
10. Insmed to Appeal Delisting Notification From Nasdaq
11. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... NEW YORK , Feb. 23, ... , a leading digital health company, and ... of telemedicine and remote patient monitoring, announce they ... reimbursements.  DN Telehealth maximizes collaboration ... real-time, extending consultations beyond a physical clinical setting ...
(Date:2/23/2017)... Atlanta, it seems everyone has a chance to express their ... expressive and dynamic community unlike any other. The businesses that ... With their newest salon in ... on that tradition with a unique, fresh approach to head ... the newest of 13 nationwide locations, each of them well-situated ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... during the 12th annual Inventors Recognition Reception at Purdue Research Park ... a faculty member in recognition of outstanding contributions to, and success with, commercializing ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
Breaking Biology Technology:
(Date:2/13/2017)... Feb. 13, 2017  RSA Conference -- RSA, a ... is designed to enhance fraud detection and investigation ... the RSA Fraud & Risk Intelligence Suite. The ... leverage additional insights from internal and external sources ... protect their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Biology News(10 mins):